Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.
Cognex stock reacts to RealSense acquisition and new In-Sight 1750 launch Cognex (CGNX) has moved into the spotlight after agreeing to acquire 3D vision specialist RealSense for about US$500 million and unveiling its In-Sight 1750 wafer identification system for semiconductor customers. The latest RealSense deal and In-Sight 1750 launch follow a strong year for Cognex, with a year-to-date share price return of 57.57% and a one-year total shareholder return of 28.66%. However, momentum has...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Cognex shares have climbed sharply in 2026, and the move now raises a clear question for investors who care about valuation: does the current price still line up with what the business earns? The stock is up 57.6% year to date, which puts real pressure on the earnings picture to support a much higher market value than at the start of the year. The planned US$500 million acquisition of RealSense, funded from existing cash and investments, can reshape Cognex's earnings path by changing how...
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.